This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I) or a salt thereof:
wherein R
1
is imidazolyl, pyridinyl or pyrimidinyl, any of which is optionally substituted by one group independently selected from C
1-3
alkyl and C
1-3
alkoxy.
本发明涉及通过化合物(I)或其盐调节α7
尼古丁乙酰胆碱受体(nAChR),其中R1为
咪唑基、
吡啶基或
嘧啶基,其中任意一种可以选择性地被一种独立于C1-3烷基和C1-3烷
氧基的基团取代。